Jian-ji Y. Pan

No. 420 Fuma Road
Fuzhou, 350014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas.

Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas.

Journal: The Lancet. Oncology

Published: April 29, 2025

Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas.

Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas.

Journal: The Lancet. Oncology

Published: April 29, 2025

MRI and 18F-BPA PET-guided targeting in boron neutron capture therapy.

MRI and 18F-BPA PET-guided targeting in boron neutron capture therapy.

Journal: Scientific reports

Published: April 09, 2025

International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).

International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version).

Journal: International journal of radiation oncology, biology, physics

Published: December 16, 2024

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.

Journal: JAMA oncology

Published: October 10, 2024

International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.

International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.

Journal: International journal of radiation oncology, biology, physics

Published: November 07, 2023

Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.

Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.

Journal: Cancer medicine

Published: June 17, 2023

MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinoma.

MRI-based deep learning model predicts distant metastasis and chemotherapy benefit in stage II nasopharyngeal carcinoma.

Journal: iScience

Published: October 06, 2022

The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.

The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2 N1 nasopharyngeal carcinoma: A multicenter retrospective study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 08, 2022

A rare anatomical variation of ileocolic veins involving in gastrocolic vein trunk: case report and literature review

A rare anatomical variation of ileocolic veins involving in gastrocolic vein trunk: case report and literature review

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: July 21, 2021

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.

Journal: BMC cancer

Published: July 20, 2021

Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.

Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.

Journal: JAMA network open

Published: September 21, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026